Friday, May 1, 2026

San Diego Padres Shortstop Kim Ha Seong Stays Hot in Atlanta Doubleheader

Major League Baseball (MLB) San Diego Padres...

2026 Milan-Cortina Olympics: Trump’s “Loser” Jab at an Athlete Ignites a Team USA Reckoning

Chloe Kim calls for empathy amid debates on social divisions at the 2026 Winter Olympics, following Trump's criticism of Hunter Hess.

Bitcoin Takes a Dip: What’s Causing the Crypto Slide?

Bitcoin shows weak investor sentiment, trading around $62,000, amid declining tech stocks and falling Crypto Fear & Greed Index.

Tag: biosimilar

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Stoboclo: How This New Osteoporosis Treatment Achieved 11.8 Billion KRW in Sales in Just One Year

Daewoong Pharmaceutical's Stoboclo, a biosimilar for osteoporosis, achieved 11.8 billion KRW in sales in its first year, marking rapid growth.

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.